Published on 27 Jan 2023 on Entrpreneur
Although headline inflation has slowed, the Fed will likely keep raising interest rates to attain its 2% target. Despite the cooling down of inflation,...
Start tracking your investments with Statfolio
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta,...
The healthcare sector (XLV) has seen “the fruits of its labor” in higher earnings growth and help...
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therap...
The FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk ...
Biotechnology uses living organisms to develop new medicines and technologies that benefit both e...
Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 2...
CVS Health's (CVS)decision to drop coverage for Humira and favor its cheaper biosimilars is hurti...
Novartis NVS presented encouraging results from a pre-specified interim analysis of the phase III...
There's a common problem with passive income: Generating it isn't as passive as investors expect....
Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechn...